RESUMEN
BACKGROUND: Insect bite hypersensitivity is an immunoglobulin (Ig)E-mediated dermatitis of horses initiated by bites of midges of the genus Culicoides. Culicoides spp. are not indigenous to Iceland and the prevalence of insect bite hypersensitivity is much higher in horses born in Iceland and exported as compared to Icelandic horses born in a Culicoides rich environment. Immunotherapy is therefore needed. OBJECTIVES: The aim of the study was to express an allergen from Culicoides in barley grain and investigate whether an immune response could be obtained in healthy Icelandic horses by oral treatment with transgenic barley expressing the allergen. STUDY DESIGN: In vivo experiment. METHODS: The allergen was expressed in barley grain with the Orfeus technique. A device was developed to treat horses orally with barley flour. Four Icelandic horses were treated with transgenic barley and 3 with control barley, in total 500 g in 7 feedings. Serum and saliva samples were collected for measuring specific antibodies. RESULTS: The allergen Cul n 2, a hyaluronidase originating from the salivary gland of Culicoides nubeculosus, was expressed in barley. Horses treated with the transgenic barley mounted a Cul n 2 specific IgG1 and IgG4/7 response in serum and saliva. The serum response was significantly different between the transgenic and control barley treated horses for both subclasses and the saliva response for IgG1. The induced serum antibodies bound to the corresponding allergen from Culicoides obsoletus, rCul o 2 and were able to partially block binding of Cul n 2 as well as Cul o 2 specific IgE from insect bite hypersensitivity affected horses. MAIN LIMITATIONS: Small number of horses. CONCLUSION: This study shows that specific antibody response can be induced in horses not exposed to Culicoides, using oral treatment with transgenic barley expressing an allergen. Further studies will determine whether this approach is a useful alternative for prevention and treatment of equine insect bite hypersensitivity.
Asunto(s)
Ceratopogonidae/inmunología , Hordeum , Enfermedades de los Caballos/inmunología , Mordeduras y Picaduras de Insectos/veterinaria , Administración Oral , Alérgenos/inmunología , Animales , Formación de Anticuerpos , Hordeum/genética , Caballos , Hipersensibilidad/veterinaria , Islandia , Mordeduras y Picaduras de Insectos/inmunologíaRESUMEN
BACKGROUND AND OBJECTIVE: Sleep problems are common in Parkinson's disease (PD) and increasingly so with disease progression. The frequency of these problems and the influence of dopaminergic treatment on sleep in early stages of PD remain unclear. We have therefore in this study examined the subjective experience of sleep problems in drug-naïve patients with early PD and how these problems developed after 1 year on dopaminergic treatment using the Parkinson's Disease Sleep Scale (PDSS). METHODS: In all, 138 drug-naïve patients with early PD derived from a population-based incident cohort and 138 age- and gender-matched control subjects were thoroughly assessed for Parkinsonism, cognition, depressive symptoms and sleep by structured interviews and clinical examination at the time of diagnosis and 1 year later on medication. Sleep problems were assessed using the PDSS. RESULTS: The total PDSS score for patients with PD was lower compared with controls, 119 vs. 127 (P < 0.05) at baseline and 121 vs. 128 (P < 0.005) after 1 year on drugs. Analyses of PDSS subdomains showed more nocturnal motor off symptoms both at baseline and after 1 year (P < 0.005) and increased daytime somnolence in patients compared with control subjects (P < 0.005 at baseline and P < 0.05 after 1 year). Only minor changes in sleep scores were seen after the introduction of dopaminergic treatment. CONCLUSION: Patients with early PD report only modestly increased subjective sleep problems at the time of diagnosis compared with control subjects and dopaminergic treatment during the first year in general only slightly changed the experienced sleep problems.
Asunto(s)
Antiparkinsonianos/efectos adversos , Agonistas de Dopamina/efectos adversos , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/tratamiento farmacológico , Trastornos del Sueño-Vigilia/complicaciones , Trastornos del Sueño-Vigilia/epidemiología , Anciano , Femenino , Humanos , Masculino , Encuestas y CuestionariosRESUMEN
BACKGROUND: The prevalence and pattern of Chlamydia trachomatis infection among women requesting induced abortion in the three year period 1992-95 was evaluated and compared to the results of a previous study in 1982-84, where the prevalence of chlamydial infection had been 13.5%. METHODS: A total of 1995 women requested termination, 1855 (93%) of whom were tested for Chlamydia and were included in the study. Two types of tests for chlamydial infection, ELISA and PCR, were used in two consecutive periods. In addition cultures for gonorrhea were done in each case. Information on age, marital status, parity, gestational age and the results of chlamydia and gonorrhea tests of the women and sexual partners were recorded. RESULTS: Chlamydia trachomatis positive women were 149 (8.0%), a significant reduction from the previous 1982-84 study (p<0.001). Women with positive tests were significantly younger (80% < or = 25 years of age; p<0.001) and more frequently single (86.6%; p<0.001), than those with negative tests, as in the previous period. Of the partners, 80.4% were contacted, and 52.1% presented for investigation. Of those tested 42.1% were Chlamydia positive. Four women (0.2%) had Neisseria gonorrhea but none of the partners. CONCLUSIONS: The prevalence of Chlamydia trachomatis is receding among women coming for termination of pregnancy. As treatment before or at operation has repeatedly been shown to be of benefit and since the prevalence is still considerable, continued screening of these women is justified.
Asunto(s)
Aborto Legal , Infecciones por Chlamydia/etiología , Chlamydia trachomatis , Gonorrea/etiología , Complicaciones Infecciosas del Embarazo/etiología , Enfermedades del Cuello del Útero/etiología , Adolescente , Adulto , Distribución por Edad , Femenino , Edad Gestacional , Humanos , Estado Civil , Persona de Mediana Edad , Paridad , Embarazo , Prevalencia , Estudios Retrospectivos , Factores de RiesgoRESUMEN
Postoperative pelvic infection is a serious complication of induced abortion, and may occur in 2-6% of cases. A study of the prevalence and distribution by age and marital status of cervical Chlamydia infection in 1991-93 in women seeking termination of pregnancy is in progress. The data for 1993 are presented and compared to results from a previous study. There were 686 women requesting termination of pregnancy in 1993. Of those 636 had induced abortion by suction evacuation, 11 aborted spontaneously, three were not pregnant, two were refused termination of pregnancy and 34 women withdrew their request. Of those who had the operation, 633 (92.3%) had samples taken and 48 were Chlamydia trachomatis positive (7.6%). The reduction from the previous study was significant where 13.5% of the women were Chlamydia positive. The Chlamydia positive women were also younger and more often single than those who were negative. It has been shown that if Chlamydia positive women are treated the incidence of later endometritis and salpingitis is not higher than among those that are negative. This emphasizes the importance of screening and treating Chlamydia positive women requesting termination of pregnancy.